minoxidil has been researched along with bimatoprost in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Makornwattana, M; Pengsalae, N; Suwanchatchai, W; Tanglertsampan, C | 1 |
| Bergfeld, W; Murad, A | 1 |
| Fortman, J; Juhász, M; Mesinkovska, NA; Rubio-Gonzalez, B | 1 |
| Cohen, PR | 1 |
| Baussard, L; Fiteni, F; Guichard, A; Le Vigouroux, S; Quesada, S | 1 |
| Cho, SS; Kim, BJ; Kim, KT; Koo, KT; Pandey, P; Park, JW; Shim, JH; Subedi, L | 1 |
| Agron, S; Friedman, PM; Geronemus, RG; Konda, A; Parker, C; Wang, JV | 1 |
| Elsaie, ML; Hashem, OA; Mahfouz, SM; Zaky, MS | 1 |
3 review(s) available for minoxidil and bimatoprost
| Article | Year |
|---|---|
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic | 2018 |
Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review.
Topics: Alopecia; Animals; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Cryotherapy; Hair Follicle; Humans; Minoxidil; Scalp | 2018 |
[Alopecia and cancers: From basics to clinical practice].
Topics: Alopecia; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Hair; Hair Follicle; Humans; Iatrogenic Disease; Immunotherapy; Minoxidil; Molecular Targeted Therapy; Neoplasms; Quality of Life; Radiotherapy; Scalp Dermatoses; Spironolactone | 2021 |
2 trial(s) available for minoxidil and bimatoprost
| Article | Year |
|---|---|
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female; Humans; Male; Middle Aged; Minoxidil; Treatment Outcome; Vasodilator Agents; Young Adult | 2012 |
Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial.
Topics: Administration, Topical; Bimatoprost; Double-Blind Method; Eyebrows; Female; Humans; Hypotrichosis; Male; Minoxidil; Treatment Outcome | 2023 |
4 other study(ies) available for minoxidil and bimatoprost
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and/or minoxidil.
Topics: Administration, Cutaneous; Alopecia; Bimatoprost; Combined Modality Therapy; Drug Delivery Systems; Female; Humans; Laser Therapy; Male; Minoxidil; Platelet-Rich Plasma; Scalp; Vasodilator Agents | 2019 |
Preparation of topical bimatoprost with enhanced skin infiltration and
Topics: Administration, Topical; Alopecia; Animals; Antioxidants; Bimatoprost; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Hair; Hair Follicle; Humans; Male; Mice; Mice, Inbred C57BL; Minoxidil; Skin Absorption; Solvents | 2022 |
Enhanced Uptake and Retention of 0.03% Bimatoprost, 0.5% 5-Fluorouracil, and 5% Minoxidil After 1,550-nm or 1,927-nm Nonablative Laser Pretreatment.
Topics: Bimatoprost; Erbium; Fluorouracil; Humans; Laser Therapy; Lasers, Solid-State; Minoxidil; Thulium | 2022 |